HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Abstract
Recent evidence suggests that K-ras protooncogene protein p21 may have a tumor-suppressive role in the context of development of lung adenocarcinoma. Levels of K-ras p21, raf-1, mitogen-activated protein kinases Erk 1 and 2, the phosphorylated-activated forms of Erk 1 and 2 (Erk 1P and 2P), and proliferating cell nuclear antigen (PCNA) were measured by immunoblotting in mouse lung tumors (5 to 9 mm in size) caused by N-nitrosodimethylamine (NDMA) and in control lungs. In tumors compared with normal lung, cell membrane-associated K-ras p21 was significantly decreased and cytosolic K-ras p21 increased. Total, membrane, and cytosolic raf-1 and Erk 1P and 2P were increased in tumors compared with normal lung. A single dose of 5 nmol/kg 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) given after NDMA resulted in a significant 2.4-fold increase in tumor multiplicity. A significantly greater decrease in membrane-associated K-ras p21 and increase in total and membrane associated raf-1 occurred in the NDMA/TCDD tumors compared with the NDMA-only tumors. PCNA levels increased in tumors, a finding confirmed by immunohistochemistry, and correlated with tumor size after NDMA/TCDD treatment but not after NDMA only. The increase in raf-1 in the tumors was confirmed by immunohistochemistry, which also revealed an increase in raf-1-positive alveolar macrophages specifically associating with tumors from the earliest stages. These results suggest a possible tumor-suppressive function for K-ras p21 in lung and a positive role for raf-1 and Erk 1/2 in lung tumorigenesis. TCDD may promote tumors by contributing to downregulation of K-ras and stimulation of raf-1.
AuthorsGayatri Ramakrishna, Christine Perella, Lisa Birely, Bhalchandra A Diwan, Laura W Fornwald, Lucy M Anderson
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 179 Issue 1 Pg. 21-34 (Feb 15 2002) ISSN: 0041-008X [Print] United States
PMID11884234 (Publication Type: Journal Article)
Chemical References
  • Carcinogens
  • Polychlorinated Dibenzodioxins
  • Proliferating Cell Nuclear Antigen
  • Proto-Oncogene Proteins c-raf
  • proto-oncogene protein v-RAF1, pig
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Oncogene Protein p21(ras)
  • Dimethylnitrosamine
Topics
  • Animals
  • Carcinogens (toxicity)
  • DNA Mutational Analysis
  • Dimethylnitrosamine (toxicity)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Immunoblotting
  • Immunohistochemistry
  • Lung Neoplasms (chemically induced, genetics, pathology)
  • Male
  • Mice
  • Mitogen-Activated Protein Kinase 1 (biosynthesis, genetics)
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases (biosynthesis, genetics)
  • Oncogene Protein p21(ras) (biosynthesis, genetics)
  • Polychlorinated Dibenzodioxins (toxicity)
  • Proliferating Cell Nuclear Antigen (metabolism)
  • Proto-Oncogene Proteins c-raf (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: